Speech-Language Pathologists in Charleroi, PA Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Ms. Paula K. Brandt, MS,SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Chamber Plaza, Diversified Human Services, Inc., Charleroi, PA 15022 Phone: 724-489-8096 Fax: 724-489-9373 |
Ms. Nancy L. Hager, MS, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Chamber Plaza, Diversified Human Services, Inc., Charleroi, PA 15022 Phone: 724-489-8096 Fax: 724-483-9373 |
Gina Dicarlo, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 625 Lincoln Ave Ste 107, Charleroi, PA 15022 Phone: 724-483-4886 Fax: 724-483-0519 |
News Archive
Immunomic Therapeutics initiates JRC-LAMP-vax vaccine Phase I trial in Sugi allergy
Immunomic Therapeutics, Inc., a leader in developing novel allergy immunotherapies, announced today that it has dosed the first patient in a Phase I clinical trial of its lead candidate, JRC-LAMP-vax vaccine, at its clinical site in Honolulu, Hawaii. Initial subjects include Japanese ex-patriates previously exposed to Japanese red cedar, or "Sugi," as it is known in Japan.
Yoga may be effective in treating patients with stress-related psychological and medical conditions
An article by researchers from Boston University School of Medicine (BUSM), New York Medical College (NYMC), and the Columbia College of Physicians and Surgeons (CCPS) reviews evidence that yoga may be effective in treating patients with stress-related psychological and medical conditions such as depression, anxiety, high blood pressure and cardiac disease.
State round-up: Tenn. lawmakers fail to pass bill to opt out of health care law; Mass. officials continue to study hospital sale
Tennessee lawmakers adjourned the 106th General Assembly early Thursday after failing to pass a bill to opt out of the new federal health care law. ... Both chambers passed the budget - the only piece of legislation they are constitutionally required to adopt - last week, but spent the last few days wrangling over issues like the federal health care overhaul.
iCAD prices underwritten public offering of 2,400,000 shares of common stock
iCAD, Inc. ("iCAD"), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy solutions for the early identification and treatment of cancer, today announced it has priced a registered firm commitment underwritten public offering of 2,400,000 shares of its common stock at a price to public of $11.00 per share.
› Verified 8 days ago
Physical Therapists
Optometrists
Occupational Therapists
Chiropractors
Speech-Language Pathologists
Podiatrists